Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity — Masatoshi Kudo (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity
Shared by
Masatoshi Kudo
Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity
Editorial Material
2023
en
Authors
Masatoshi Kudo
Abstract
1 min read
NA
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Editorial Material
2023
All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
Masatoshi Kudo
Editorial Material
2018
Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma
Masatoshi Kudo
Article
2018
Systemic Therapy for Hepatocellular Carcinoma: Recent Advances
Masatoshi Kudo
Article
2018
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Masatoshi Kudo
Article
2017
Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.